SAPPHIRE RESULTS

Princeton Research Division in Princeton, New Jersey conducted an independent clinical study. The clinical trial was performed with 35 live subjects for a period of 24 weeks (6 months).

The results at this interim stage indicates that using the device three times per week for the first 4 weeks and at least once a week for the second month shows a reduction in Mean Total Open Comedones 60.74% compared to baseline totals. Mean Total Pustule counts reduced by 46.78%, compared to baseline.

WATCH THE VIDEO OF DERMATOLOGIST’S REVIEW OF BLUE LIGHT THERAPY

NOTICED A REDUCTION IN THE SIZE OF THEIR BLEMISHES

NOTICED A REDUCTION IN THE REDNESS OF THEIR BLEMISHES

NOTICED THE PAIN OF THEIR ACNE WAS SOOTHED

AGREED THAT THEY FELT THEIR BLEMISHES WERE VISIBLY REDUCTED

AGREED THAT THEY FELT HAPPIER WITH THEIR COMPLEXION.

FELT THAT THE DEVICE WAS EASY TO USE

94%

AGREED THAT THE DEVICE DID NOT MAKE THEIR SKIN IRRITATED, RED OR BLOTCHY

91%

NOTICED THEIR COMPLEXION LOOKED CLEARER

91%

FELT THEIR BLIMISHES RESOLVED FASTER

94%

AGREED THAT THEIR SKIN APPEARED CLEARER AFTER USINF THE DEVICE

The blue light penetrates into the pores and directly kills p. bacteria growing inside the skin. The increased blood flow to the treated area provides protein, nutrients, and oxygen to naturally heal and improve the skin.

Research has shown that blue light therapy helps relieve acne symptoms and reduce acne. When used as directed, results can be expected in as little as 14 days with no side effects or pain. Blue light therapy is suitable for all ages.